Skip to content
Home/Companies/Biotech/Synboli

Synboli

Biotech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Synboli?

Synboli is a French Biotech company, currently owned by Aquiti Gestion since 2025.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Aquiti Gestion
Investor
Aquiti Gestion
AVA 1 (Aquiti Venture Amorcage) · 2024 · VC

Key facts

HQFrance
SectorBiotech

More from AVA 1 (Aquiti Venture Amorcage)

Other portfolio companies in the same fund.

Aqqi
Active
France
Boli
Boli
Active
HealthTechFrance
Chilli
Active
ConsumerFrance
Debeaulieu
Active
IndustrialsFrance
Maison Mitteault
Active
France
Prodontis
Active
HealthcareFrance

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Synboli?

Synboli is currently owned by Aquiti Gestion, through AVA 1 (Aquiti Venture Amorcage), since 2025.

When did Aquiti Gestion acquire Synboli?

Aquiti Gestion acquired Synboli in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue